Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Atlassian Corporation

TEAM
Technology · Software - Application

Atlassian Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is topping out (1 weeks in). Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.

Price
$110
−39.7% 1Y
Revenue (Mar 26)
$1.8 B
+31.6% YoY
Profit (Mar 26)
$−0.1 B
Operating margin
−3.4%
−2.7 pp YoY
ROE
−19%
FY25
ROIC
4.6%
vs WACC 10.0% → −5.4 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Atlassian Corporation trades at $110, losing momentum at the top and 1 weeks into that stage. That is +1.6% against its own 200-day average. It sits at 44% of a 52-week range of $57 to $178. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks.

Today the stock is losing momentum at the top — week 1 of stage 3. At $110 it trades +1.6% versus its 200-day average and sits at 44% of its 52-week range ($57–$178).

Aug 26: $110 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+1.6% versus the 200-day line, week 1 of stage 3
Price50-day avg200-day avg
S3S2S1S3S1S4$335$260$186$111$36.6$$110$108Jul 23Apr 24Jan 25Oct 25Aug 26
S3S2S1S3S1S4$335$260$186$111$36.6$$110$108Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (527 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +309% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

P/E does not price Atlassian Corporation — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. On sales the market values Atlassian Corporation at 5.4× its FY25 revenue of $5.2 B.

With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.

PEG 0.69 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
5.6×4.3×3.0×1.7×0.3××0.69×Sep 21Sep 22Dec 23Dec 24Mar 26
5.6×4.3×3.0×1.7×0.3××0.69×Sep 21Dec 23Mar 26
P/E
earnings negative
PEG
0.90
as reported

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Atlassian Corporation reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +19.7% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
35%31%27%23%19%%19.7%FY21FY23FY25
35%31%27%23%19%%19.7%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising
Revenue
27%25%23%21%19%%23.8%Jun 23Sep 24Mar 26
27%25%23%21%19%%23.8%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
−3.7%−6.2%−8.7%−11%−14%%−9.2%Jun 23Dec 23Sep 24Jun 25Mar 26
−3.7%−6.2%−8.7%−11%−14%%−9.2%Jun 23Sep 24Mar 26
Revenue growth
Steady high
latest +23.8% · span +19.5% to +26.4%
ROCE
Falling
latest −9.2% · span −13.0%–−4.4%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+19.7%+23.1%
Stock price−39.7%−17.8%−19.9%+13.2%
Revenue YoY (Mar 26)
+31.6%
latest quarter vs a year ago
Revenue 10y
25.7%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

39.9/100 — rank 24 of 30 in Software - Application · 61% evidence confidence

Atlassian Corporation scores 39.9 out of 100 against the 30 companies it is compared with in Software - Application, ranking 24. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 13.5 + 4.8 + 10 + 11.6 = 39.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Atlassian Corporation reported $1.8 B of revenue in the Mar 26 quarter, +31.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 25.7% a year. The last full year, FY25, came in at $5.2 B. The last four reported quarters add to $6.2 B.

FY25 revenue came in at $5.2 B (+19.7% on the year), capping 4 years at 25.7% compound. The latest quarter (Mar 26) printed $1.8 B, +31.6% year on year — the 12th consecutive quarter of year-over-year growth.

FY25 revenue $5.2 B (+19.7% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
25.7% a year over 4 years
RevenueYoY growth
5.635%4.231%2.827%1.423%0.019%$ B%$5B19.7%FY21FY23FY25
5.635%4.231%2.827%1.423%0.019%$ B%$5B19.7%FY21FY23FY25
Mar 26: $1.8 B (+31.6% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
1.933%1.429%1.024%0.520%0.016%$ B%$2B31.6%Jun 23Sep 24Mar 26
1.933%1.429%1.024%0.520%0.016%$ B%$2B31.6%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +23.5% growth against the decade's 25.7% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +23.8% over the last 4 quarters against +22.3%/yr over the last 8 — stabilising.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Atlassian Corporation's operating margin is −3.4% in the Mar 26 quarter, −2.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −9.9% to 6.7%. The current quarter sits inside that band.

The latest quarter's operating margin is −3.4%, −2.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −9.9%–6.7%.

🚨 Why the margin moved: operating margin went −2.7 pp year on year while gross margin went +1.1 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: −2.5% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −9.9–6.7% band over 5 years
operating marginYoY change (pp)
8.0%8.7%3.2%3.0%−1.6%−2.7%−6.4%−8.3%−11%−14%%%−2.5%0.3%FY21FY23FY25
8.0%8.7%3.2%3.0%−1.6%−2.7%−6.4%−8.3%−11%−14%%%−2.5%0.3%FY21FY23FY25
Mar 26: −3.4% operating margin (−2.7 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
−0.2%17%−2.0%11%−3.8%5.6%−5.7%−0.3%−7.5%−6.1%%%−3.4%−2.7%Jun 23Sep 24Mar 26
−0.2%17%−2.0%11%−3.8%5.6%−5.7%−0.3%−7.5%−6.1%%%−3.4%−2.7%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Atlassian Corporation posted a net loss of $0.1 B in the Mar 26 quarter. The full FY25 year was a loss of $0.3 B. That loss is 5.6% of the quarter's revenue. The same quarter a year earlier lost $0.1 B. 12 of the last 12 reported quarters were loss-making.

Mar 26 profit was $−0.1 B, null year on year. On the full year, FY25 printed $−0.3 B (null).

FY25 profit $−0.3 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profit
0.0−0.1−0.3−0.5−0.6$ B$−0BFY21FY23FY25
0.0−0.1−0.3−0.5−0.6$ B$−0BFY21FY23FY25
Mar 26: $−0.1 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
0.01−0.03−0.06−0.09−0.13$ B$−0BJun 23Sep 24Mar 26
0.01−0.03−0.06−0.09−0.13$ B$−0BJun 23Sep 24Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Atlassian Corporation's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $1.5 B of operating cash against $−0.3 B of profit. After $0.0 B of capital spending, $1.4 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $1.5 B against reported profit of $−0.3 B, leaving free cash of $1.4 B after $0.0 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $1.5 B vs profit $−0.3 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
1.61.00.4−0.2−0.7$ B$2B$−0B$1BFY21FY23FY25
1.61.00.4−0.2−0.7$ B$2B$−0B$1BFY21FY23FY25
Mar 26: operating cash $0.6 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)100%
0.7101.2%0.5100.6%0.4100.0%0.299.4%0.098.8%$ B%$1BJun 23Sep 24Mar 26
0.7101.2%0.5100.6%0.4100.0%0.299.4%0.098.8%$ B%$1BJun 23Sep 24Mar 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Atlassian Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.080.060.040.020.00$ B$0BFY21FY23FY25
0.080.060.040.020.00$ B$0BFY21FY23FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.0110.70.0080.50.0050.40.0030.20.0000.0$ B$ B$0B$1BJun 23Sep 24Mar 26
0.0110.70.0080.50.0050.40.0030.20.0000.0$ B$ B$0B$1BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Atlassian Corporation earns a ROE of −19% in FY25. That is up from a trough of −200% in FY21. Return on invested capital clears the cost of that capital by −5.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −5.0% net margin on 0.86× asset turns.

FY25 ROE is −19%, recovered from a FY21 trough of −200% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): −5.0% net margin × 0.86× asset turns × 4.47× balance-sheet leverage ≈ −19.2% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 4.6% − 10.0% = a −5.4 pp spread. The 10.0% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE −19% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 10.0% cost of capital used on this page.
the climb back from FY21's −200%
ROEROIC (annual)WACC
1,121%−2,906%−6,933%−10,961%−14,988%%−19.3%−13,876.9%FY21FY23FY25
1,121%−2,906%−6,933%−10,961%−14,988%%−19.3%−13,876.9%FY21FY23FY25
Mar 26: ROIC −7.9% (TTM) vs WACC 10.0% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
22,658%−56,828%−1,36,314%−2,15,800%−2,95,286%%−7.9%−18.1%Jun 23Sep 24Mar 26
22,658%−56,828%−1,36,314%−2,15,800%−2,95,286%%−7.9%−18.1%Jun 23Sep 24Mar 26
11 · Dividend

Dividend

Atlassian Corporation pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Atlassian Corporation does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Atlassian Corporation carries total debt of $1.2 B against shareholder equity of $0.9 B as of Mar 26, a debt-to-equity of 1.41. On the annual view that ratio went from 0.00 in FY15 to 0.92 in FY25. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of $1.2 B against shareholder equity of $0.9 B — a debt-to-equity of 1.41. On the annual view, debt-to-equity went from 0.00 (FY15) to 0.92 (FY25). Read the returns on this page with that leverage in mind.

FY25: debt $1.2 B at 0.92× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 6-year window.
Total debtDebt-to-equity
1.44.3×1.13.1×0.72.0×0.40.8×0.0−0.3×$ B×$1B0.92×FY15FY22FY25
1.44.3×1.13.1×0.72.0×0.40.8×0.0−0.3×$ B×$1B0.92×FY15FY22FY25
Mar 26: debt $1.2 B, debt-to-equity 1.41 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
1.42.1×1.01.7×0.71.4×0.31.0×0.00.7×$ B×$1B1.41×Jun 23Sep 24Mar 26
1.42.1×1.01.7×0.71.4×0.31.0×0.00.7×$ B×$1B1.41×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

11.2% of Atlassian Corporation's tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 4.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 11.2% of the float is sold short, and at typical trading volumes it would take about 4.2 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
11.2%
of the tradable float
Days to cover
4.2
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Atlassian Corporation: the Z-score reads 4.79. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 4.79 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 4.79.

15 · Related companies · Software - Application
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Zoom Communications, Inc.ZM 63.9/100Mixed-positive evidence85% evidence ASLEEP 21.4/35 Revenue 5% · PAT 97.5% · OPM change 4.5 pp 95% evidence 13.1/25 ROCE 3.2% · OPM 25.1% 76% evidence 16.1/20 P/E 14.3× · PEG 0.55 65% evidence 13.3/20 RS sector 15.8% · RS bench 5.3% · 1Y 42.7%4 of 12 weeks ahead 100% evidence
Exact sum: 21.4 + 13.1 + 16.1 + 13.3 = 63.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Autodesk, Inc.ADSK 62.7/100Mixed-positive evidence85% evidence BASING 29.4/35 Revenue 18.3% · PAT 44.6% · OPM change 13.7 pp 95% evidence 15.9/25 ROCE 8.8% · OPM 28% 76% evidence 12.9/20 P/E 34.5× · PEG 0.74 65% evidence 4.5/20 RS sector -8.5% · RS bench -19.5% · 1Y -18.4%0 of 12 weeks ahead 100% evidence
Exact sum: 29.4 + 15.9 + 12.9 + 4.5 = 62.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.5% and the one-year return is -18.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
3Automatic Data Processing, Inc.ADP 60.1/100Thin evidence · provisional58% evidence BREAKING OUT 16.2/35 Revenue — · PAT — · OPM change 0.7 pp 45% evidence 16.8/25 ROCE 10% · OPM 30.1% 76% evidence 10.1/20 P/E 20.5× · PEG — 15% evidence 17.0/20 RS sector 10.8% · RS bench -2% · 1Y -11.5%6 of 12 weeks ahead 100% evidence
Exact sum: 16.2 + 16.8 + 10.1 + 17 = 60.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Paychex, Inc.PAYX 59.9/100Mixed-positive evidence85% evidence BREAKING OUT 20.9/35 Revenue 16.9% · PAT 6.3% · OPM change 7.5 pp 95% evidence 15.9/25 ROCE 6.4% · OPM 37.7% 76% evidence 6.6/20 P/E 19.8× · PEG 2.83 65% evidence 16.5/20 RS sector 10% · RS bench -2.8% · 1Y -16%5 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 15.9 + 6.6 + 16.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Snowflake Inc.SNOW 59.0/100Mixed-positive evidence64% evidence BREAKING OUT 25.3/35 Revenue 31.1% · PAT — · OPM change 19.5 pp 71% evidence 4.0/25 ROCE -6.6% · OPM -23.4% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 19.7/20 RS sector 49% · RS bench 32.7% · 1Y 65.2%11 of 12 weeks ahead 100% evidence
Exact sum: 25.3 + 4 + 10 + 19.7 = 59 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Workday, Inc.WDAY 57.6/100Mixed-positive evidence85% evidence BREAKING OUT 26.3/35 Revenue 13.3% · PAT 73.9% · OPM change 11.6 pp 95% evidence 10.3/25 ROCE 3.1% · OPM 13.3% 76% evidence 7.7/20 P/E 38.3× · PEG 2.14 65% evidence 13.3/20 RS sector -0.1% · RS bench -13.9% · 1Y -22.9%5 of 12 weeks ahead 100% evidence
Exact sum: 26.3 + 10.3 + 7.7 + 13.3 = 57.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Fair Isaac CorporationFICO 57.2/100Thin evidence · provisional58% evidence ASLEEP 24.5/35 Revenue — · PAT — · OPM change 8.9 pp 45% evidence 21.5/25 ROCE 30.4% · OPM 58.2% 76% evidence 9.8/20 P/E 34.5× · PEG — 15% evidence 1.4/20 RS sector -23.9% · RS bench -33.2% · 1Y -20.7%3 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 21.5 + 9.8 + 1.4 = 57.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8SS&C Technologies Holdings, Inc.SSNC 55.1/100Thin evidence · provisional58% evidence TURNING 18.2/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 12.6/25 ROCE 2.8% · OPM 24.2% 76% evidence 10.7/20 P/E 17.8× · PEG — 15% evidence 13.6/20 RS sector 5% · RS bench -6.9% · 1Y -6.6%3 of 12 weeks ahead 100% evidence
Exact sum: 18.2 + 12.6 + 10.7 + 13.6 = 55.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Guidewire Software, Inc.GWRE 53.1/100Mixed-positive evidence75% evidence TURNING 27.3/35 Revenue 25% · PAT 100% · OPM change 6.7 pp 95% evidence 7.1/25 ROCE 1.5% · OPM 8.2% 76% evidence 8.9/20 P/E 74.8× · PEG — 15% evidence 9.8/20 RS sector -5.9% · RS bench -18.7% · 1Y -24.8%1 of 12 weeks ahead 100% evidence
Exact sum: 27.3 + 7.1 + 8.9 + 9.8 = 53.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10SAP SESAP 52.9/100Thin evidence · provisional58% evidence TURNING 18.7/35 Revenue — · PAT — · OPM change 2.8 pp 45% evidence 14.2/25 ROCE 5% · OPM 28.7% 76% evidence 10.5/20 P/E 19.8× · PEG — 15% evidence 9.5/20 RS sector -6.5% · RS bench -18.5% · 1Y -33.1%1 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 14.2 + 10.5 + 9.5 = 52.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Cadence Design Systems, Inc.CDNS 52.7/100Thin evidence · provisional58% evidence ASLEEP 19.8/35 Revenue — · PAT — · OPM change 0.2 pp 45% evidence 14.8/25 ROCE 4.9% · OPM 29.3% 76% evidence 9.0/20 P/E 74.6× · PEG — 15% evidence 9.1/20 RS sector 2.7% · RS bench -7.4% · 1Y -3.2%8 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 14.8 + 9 + 9.1 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Intuit Inc.INTU 52.5/100Mixed-positive evidence85% evidence BASING 19.6/35 Revenue 15% · PAT 32.2% · OPM change -1 pp 95% evidence 18.1/25 ROCE 14.9% · OPM 47% 76% evidence 13.6/20 P/E 23.5× · PEG 0.69 65% evidence 1.2/20 RS sector -32.9% · RS bench -42.6% · 1Y -56.8%0 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 18.1 + 13.6 + 1.2 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Salesforce, Inc.CRM 52.2/100Mixed-positive evidence85% evidence TURNING 19.1/35 Revenue 11% · PAT 29.3% · OPM change 1.3 pp 95% evidence 11.9/25 ROCE 3.1% · OPM 21.1% 76% evidence 14.8/20 P/E 20.4× · PEG 0.58 65% evidence 6.4/20 RS sector -8.2% · RS bench -19.4% · 1Y -20.6%0 of 12 weeks ahead 100% evidence
Exact sum: 19.1 + 11.9 + 14.8 + 6.4 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Roper Technologies, Inc.ROP 51.5/100Thin evidence · provisional58% evidence TURNING 16.6/35 Revenue — · PAT — · OPM change -0.7 pp 45% evidence 12.2/25 ROCE 1.9% · OPM 27.2% 76% evidence 11.2/20 P/E 14× · PEG — 15% evidence 11.5/20 RS sector -1.8% · RS bench -13.9% · 1Y -26.5%2 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 12.2 + 11.2 + 11.5 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
15Adobe Inc.ADBE 50.8/100Mixed-positive evidence85% evidence BASING 15.9/35 Revenue 11.5% · PAT 5.2% · OPM change -2.1 pp 95% evidence 17.7/25 ROCE 12.1% · OPM 33.8% 76% evidence 12.1/20 P/E 14.8× · PEG 1.25 65% evidence 5.1/20 RS sector -9.2% · RS bench -20.6% · 1Y -24.5%0 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 17.7 + 12.1 + 5.1 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16PTC Inc.PTC 46.4/100Thin evidence · provisional58% evidence BASING 17.7/35 Revenue — · PAT — · OPM change 3.1 pp 45% evidence 13.9/25 ROCE 3.1% · OPM 38.2% 76% evidence 11.4/20 P/E 11× · PEG — 15% evidence 3.4/20 RS sector -11.2% · RS bench -22.3% · 1Y -31%0 of 12 weeks ahead 100% evidence
Exact sum: 17.7 + 13.9 + 11.4 + 3.4 = 46.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
17Datadog, Inc.DDOG 43.9/100Mixed-negative evidence81% evidence LEADER 18.3/35 Revenue 29.5% · PAT -18% · OPM change 2.3 pp 83% evidence 6.3/25 ROCE 0.2% · OPM 0.7% 76% evidence 3.6/20 P/E 302.7× · PEG 4.93 65% evidence 15.7/20 RS sector 71.9% · RS bench 58.3% · 1Y 120.1%12 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 6.3 + 3.6 + 15.7 = 43.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Dynatrace, Inc.DT 43.8/100Mixed-negative evidence71% evidence BREAKING OUT 12.3/35 Revenue 18.9% · PAT -66.5% · OPM change -2.6 pp 83% evidence 9.3/25 ROCE 1.3% · OPM 7% 76% evidence 9.2/20 P/E 68.5× · PEG — 15% evidence 13.0/20 RS sector 7.8% · RS bench -4.3% · 1Y -1.1%9 of 12 weeks ahead 100% evidence
Exact sum: 12.3 + 9.3 + 9.2 + 13 = 43.8 · Decision use: Price leads the evidence: RS versus the benchmark is -4.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
19Shopify Inc.SHOP 42.9/100Mixed-negative evidence74% evidence TURNING 22.8/35 Revenue 31.9% · PAT 56% · OPM change 3.5 pp 62% evidence 9.9/25 ROCE 3.2% · OPM 12.1% 76% evidence 4.2/20 P/E 117.4× · PEG 4.21 65% evidence 6.0/20 RS sector -7.5% · RS bench -18.5% · 1Y -17.8%1 of 12 weeks ahead 100% evidence
Exact sum: 22.8 + 9.9 + 4.2 + 6 = 42.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.5% and the one-year return is -17.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
20Uber Technologies, Inc.UBER 42.9/100Mixed-negative evidence71% evidence ASLEEP 17.7/35 Revenue 18.3% · PAT -29.8% · OPM change 4 pp 83% evidence 11.3/25 ROCE 4.3% · OPM 14.6% 76% evidence 10.6/20 P/E 17.9× · PEG — 15% evidence 3.3/20 RS sector -10.2% · RS bench -20.6% · 1Y -19.6%0 of 12 weeks ahead 100% evidence
Exact sum: 17.7 + 11.3 + 10.6 + 3.3 = 42.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21ServiceNow, Inc.NOW 42.0/100Thin evidence · provisional58% evidence BREAKING OUT 14.0/35 Revenue — · PAT — · OPM change -1.3 pp 45% evidence 9.9/25 ROCE 1% · OPM 13.3% 76% evidence 9.3/20 P/E 62× · PEG — 15% evidence 8.8/20 RS sector -9% · RS bench -21.7% · 1Y -32.3%4 of 12 weeks ahead 100% evidence
Exact sum: 14 + 9.9 + 9.3 + 8.8 = 42 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Fiserv, Inc.FISV 41.8/100Mixed-negative evidence81% evidence BASING 8.7/35 Revenue 1.9% · PAT -20.1% · OPM change -8.9 pp 83% evidence 11.5/25 ROCE 1.6% · OPM 18.3% 76% evidence 15.6/20 P/E 9.5× · PEG 0.6 65% evidence 6.0/20 RS sector -22.2% · RS bench -33.8% · 1Y -58.1%0 of 12 weeks ahead 100% evidence
Exact sum: 8.7 + 11.5 + 15.6 + 6 = 41.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
23Tyler Technologies, Inc.TYL 40.8/100Thin evidence · provisional58% evidence BASING 16.9/35 Revenue — · PAT — · OPM change 0.5 pp 45% evidence 11.7/25 ROCE 2.3% · OPM 16.3% 76% evidence 9.4/20 P/E 38.8× · PEG — 15% evidence 2.8/20 RS sector -20.2% · RS bench -30.8% · 1Y -47.3%0 of 12 weeks ahead 100% evidence
Exact sum: 16.9 + 11.7 + 9.4 + 2.8 = 40.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24Atlassian Corporationthis pageTEAM 39.9/100Mixed-negative evidence61% evidence BREAKING OUT 13.5/35 Revenue 24% · PAT — · OPM change -2.2 pp 62% evidence 4.8/25 ROCE -2.2% · OPM -3.1% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 11.6/20 RS sector -2.9% · RS bench -17.2% · 1Y -34.4%10 of 12 weeks ahead 100% evidence
Exact sum: 13.5 + 4.8 + 10 + 11.6 = 39.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Grab Holdings LimitedGRAB 38.3/100Mixed-negative evidence64% evidence ASLEEP 20.9/35 Revenue 21.8% · PAT — · OPM change 5 pp 62% evidence 5.7/25 ROCE 0.3% · OPM 2.3% 76% evidence 8.5/20 P/E 366× · PEG — 15% evidence 3.2/20 RS sector -15.7% · RS bench -26.4% · 1Y -23.8%0 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5.7 + 8.5 + 3.2 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Unity Software Inc.U 37.8/100Mixed-negative evidence61% evidence BREAKING OUT 8.7/35 Revenue 7.5% · PAT — · OPM change -39.7 pp 62% evidence 4.1/25 ROCE -6.5% · OPM -69.1% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 15.0/20 RS sector 10.4% · RS bench -4.2% · 1Y 5.9%12 of 12 weeks ahead 100% evidence
Exact sum: 8.7 + 4.1 + 10 + 15 = 37.8 · Decision use: Price leads the evidence: RS versus the benchmark is -4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
27Figma, Inc.FIG 31.9/100Thin evidence · provisional55% evidence BREAKING OUT 13.3/35 Revenue 41.4% · PAT — · OPM change -58.6 pp 62% evidence 3.9/25 ROCE -9.3% · OPM -41.2% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 4.7/20 RS sector -16.3% · RS bench -30.2% · 1Y -65.3%5 of 12 weeks ahead 70% evidence
Exact sum: 13.3 + 3.9 + 10 + 4.7 = 31.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Strategy IncMSTR 26.0/100Thin evidence · provisional54% evidence ASLEEP 9.8/35 Revenue — · PAT — · OPM change -6310.1 pp 45% evidence 5.2/25 ROCE -14.3% · OPM — 61% evidence 10.8/20 P/E 15× · PEG — 15% evidence 0.2/20 RS sector -45% · RS bench -53.6% · 1Y -75.3%2 of 12 weeks ahead 100% evidence
Exact sum: 9.8 + 5.2 + 10.8 + 0.2 = 26 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Bending Spoons S.p.A.BSP 51.0/100Thin evidence · provisional24% evidence 17.8/35 Revenue — · PAT — · OPM change 13.5 pp 13% evidence 13.2/25 ROCE 5.5% · OPM 38.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.8 + 13.2 + 10 + 10 = 51 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Quantinuum Inc.QNT 41.6/100Thin evidence · provisional20% evidence 16.1/35 Revenue — · PAT — · OPM change -1316.6 pp 13% evidence 5.5/25 ROCE -9% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 16.1 + 5.5 + 10 + 10 = 41.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Atlassian Corporation's stock price today?

Atlassian Corporation trades at $110, −39.7% over the past year. The company is valued at $28.0 B. The stock sits at 44% of its 52-week range of $57–$178, +1.6% versus its 200-day average. On the tape, the price is topping out, 1 weeks in. — as of 5 August 2026.

What were Atlassian Corporation's latest quarterly results?

Atlassian Corporation reported revenue of $1.8 B and a net loss of $0.1 B for the Mar 26 quarter. Earnings per share were $−0.38. The operating margin was −3.4%, 2.7 pp lower than a year earlier. — as of 5 August 2026.

What is Atlassian Corporation's revenue?

Atlassian Corporation reported revenue of $1.8 B in the Mar 26 quarter, +31.6% year on year. For the full FY25 fiscal year, revenue was $5.2 B (+19.7%). Over the last 4 years revenue compounded at 25.7% a year. — as of 5 August 2026.

What is Atlassian Corporation's profit?

Atlassian Corporation earned $−0.1 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−0.3 B. The operating margin ran −3.4% in the latest quarter. — as of 5 August 2026.

What is Atlassian Corporation's market cap?

Atlassian Corporation's market capitalisation is $28.0 B at a stock price of $110. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

Does Atlassian Corporation pay a dividend?

No — Atlassian Corporation has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

How is Atlassian Corporation performing?

Atlassian Corporation is topping out, 1 weeks in. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

Is Atlassian Corporation in an uptrend?

It is stalling — the price is topping out (week 1 of stage 3), trading +1.6% versus its 200-day average and at 44% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is Atlassian Corporation beating the market?

On recent form, yes — Atlassian Corporation has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +309% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.

Will Atlassian Corporation's stock price go up?

This page publishes no price forecast for Atlassian Corporation. What it measures instead: the stock price is $110, the price is topping out 1 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Atlassian Corporation?

Yes — short interest is 11.2% of Atlassian Corporation's tradable float, about 4.2 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Does Atlassian Corporation have too much debt?

It carries real leverage — Atlassian Corporation's debt-to-equity is 1.41. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.

What is Atlassian Corporation's capex?

Atlassian Corporation spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.

What is Atlassian Corporation's cash flow?

Atlassian Corporation generated $1.5 B of operating cash flow in FY25 and $1.4 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.3 B, so operating cash ran ahead of profit. — as of 5 August 2026.

How financially safe is Atlassian Corporation?

On the balance sheet, the Z-score reads 4.79 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.

Where is Atlassian Corporation in its business cycle?

Atlassian Corporation's FY25 operating margin was −2.5%, against a 5-year band of −9.9%–6.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −3.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Atlassian Corporation story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Atlassian Corporation a stock worth studying right now?

This is not investment advice. The machine read: Atlassian Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI